- Home
- SGMO vs BWG Comparison
SGMO vs BWG Comparison
Compare SGMO & BWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- BWG
- Stock Information
- Founded
- SGMO 1995
- BWG 2012
- Country
- SGMO United States
- BWG United States
- Employees
- SGMO N/A
- BWG N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- BWG Finance/Investors Services
- Sector
- SGMO Health Care
- BWG Finance
- Exchange
- SGMO Nasdaq
- BWG Nasdaq
- Market Cap
- SGMO 122.8M
- BWG 136.3M
- IPO Year
- SGMO 2000
- BWG N/A
- Fundamental
- Price
- SGMO $0.59
- BWG $8.30
- Analyst Decision
- SGMO Buy
- BWG
- Analyst Count
- SGMO 6
- BWG 0
- Target Price
- SGMO $4.50
- BWG N/A
- AVG Volume (30 Days)
- SGMO 5.2M
- BWG 53.8K
- Earning Date
- SGMO 08-05-2025
- BWG 01-01-0001
- Dividend Yield
- SGMO N/A
- BWG 11.37%
- EPS Growth
- SGMO N/A
- BWG N/A
- EPS
- SGMO N/A
- BWG N/A
- Revenue
- SGMO $63,756,000.00
- BWG N/A
- Revenue This Year
- SGMO $1.29
- BWG N/A
- Revenue Next Year
- SGMO $1.60
- BWG N/A
- P/E Ratio
- SGMO N/A
- BWG N/A
- Revenue Growth
- SGMO 239.92
- BWG N/A
- 52 Week Low
- SGMO $0.41
- BWG $6.86
- 52 Week High
- SGMO $3.18
- BWG $8.65
- Technical
- Relative Strength Index (RSI)
- SGMO 60.91
- BWG 46.87
- Support Level
- SGMO $0.50
- BWG $8.21
- Resistance Level
- SGMO $0.65
- BWG $8.44
- Average True Range (ATR)
- SGMO 0.04
- BWG 0.10
- MACD
- SGMO 0.01
- BWG -0.03
- Stochastic Oscillator
- SGMO 64.22
- BWG 25.71
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About BWG BrandywineGLOBAL Global Income Opportunities Fund Inc.
BrandywineGLOBAL - Global Income Opportunities Fund Inc is a non-diversified, closed-end management investment company. The primary investment objective is to provide current income. The secondary investment objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing, under normal market conditions, at least 80% of its assets in world-wide fixed-income securities.